Effects of (-)-stepholidine on NMDA receptors: Comparison with haloperidol and clozapine

Acta Pharmacologica Sinica

Volumn 28, Issue 7, 2007, Pages 953-958

  Gu, Wei Hua ^a   Yang, Shen ^a   Shi, Wei Xing ^b   Zhen, Xue Chu ^a   Jin, Guo Zhang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

( ) stepholidine; Calcium imaging; Clozapine; Haloperidol; Neuroleptics; NMDA receptor

Indexed keywords

CLOZAPINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; STEPHOLIDINE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL;

ANIMALS; ANTIPSYCHOTIC AGENTS; BERBERINE; CALCIUM; CELL LINE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; HUMANS; PROTEIN SUBUNITS; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34347394551     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00581.x     Document Type: Article

References (30)

1. Laruelle M, Kegeles LS, Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann NY Acad Sci (2003 1003 : 138 58.
2. Jin GZ, Hu ZT, Fu Y. (-)STepholidine: a potential novel antipsychotic drug with dual D1 receptor a gonist and D2 receptor antagonist actions. Trends Pharmacol Sci (2002 23 : 4 7.
3. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev (1999 51 : 7 61.
4. Leveque JC, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S et al. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci (2000 20 : 4011 20.
5. Meltzer HY. The mechanism of action of novel antipsyhotic drugs. Schizophr Bull (1991 17 : 263 87.
6. Yamamoto BK, Cooperman MA. Differntial effects of chornic antipsychotic drugs treatmlent on extracellular glutamate and dopamine concentrations. J Neurosci (1994 14 : 4159 66.
7. Arvanov VL, Wang RY. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharmacol Exp Ther 1999 289 : 1000 6.
8. Ilyin VI, Whittermore ER, Guastella J, Weber E, Woodward RM. Subtype-selective inhibition of N-methy1-D-aspartate receptors by haloperidol. Mol Pharmacol 1996 50 : 1541 50.
9. Levine JB, Martin G, Wilson A, Treistman SN. Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner. Neurosci Lett 2003 346 : 125 8.
10. Itil T, Keskiner A, Kiremitci N, Holden JM. Effect of phencylidine in chronic schizophrenics. Can Psychiatr Assoc J 1967 12 : 209 12.
11. Wu DC, Xing XZ, Wang WA, Xie H, Wang YH, Wang XY, et al. A double blind comparison trial of l - stepholidine and perphenazine in treatment of schizophrenia. Chin J New Drugs Clin Rem 2003 22 : 155 60. Chinese.
12. Zhang XX, Sun BC, Jin GZ. Atypical neuroleptic properties of l-stepholidine. Sci China (1997 40 : 531 8.
13. Ellenbroek BA, Zhang XX, Jin GZ. Effects of (-) stepholidine in animal models for schizophrenia. Acta Pharmacol Sin 2006 27 : 1111 8.
14. Zhu ZT, Fu Y, Hu GY, Jin GZ. Modulation of medial prefrontal cortical D1 receptors on the excitatory firing of nucleus accumbens neurons elicited by (-)-stepholidine. Life Sci (2006 67 : 1265 74.
15. Mo YQ, Jin XL, Chen YT, Jin GZ, Shi WX. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Neuropsychopharmacology 2005 30 : 261 7.
16. Gao M, Liu CL, Yang S, Jin GZ. l-stepholidine increase the frequency of sEPSCs in rat prefrontal cortical neurons. Acta Pharmacol Sin 2007 28 : 627 33.
17. Yang CR, Chen L. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment. Neuroscientist 2005 11 : 452 70.
18. Cik M, Chazot PL, Stephenson FA. Optimal expression of cloned NMDAR1/NMDAR2A heteromeric glutamate receptors: a biochemical characterization. Biochem J 1993 296 : 877 83.
19. Blevins T, Mirshahi T, Chandler LJ, Woodward JJ. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells. J Neurochem 1997 69 : 2345 54.
20. Grishin AA, Gee CE, Gerber U, Benquet P. Differential calciumdependent modulation of NMDA currents in CA1 and CA3 hippocampal pyramindal cells. J Neurosci 2004 24 : 350 5.
21. Gu WH, Yang S, Shi WX, Zhen XC, Jin GZ. Requiring PSD-95 for dopamine D1 receptor modulating NMDA receptor function. Acta Pharmacol Sin 2007 28 : 756 62.
22. Kelly MW, Perry PJ, Coryell WH, Miller DD, Arndt SV. Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia. Psychopharmacology (Berl) 1990 102 : 514 20.
23. Bennett JA, Keck PE Jr. A target-dose finding study of clozapine in patients with schizophrenia. Ann Clin Psychiatry 1996 8 : 19 21.
24. Perry PJ, Miller DD, Arndt SV, Cadoret RJ. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 1991 148 : 231 5.
25. Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, et al. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 1999 56 : 21 7.
26. Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, et al. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 2005 57 : 577 85.
27. Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, et al. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biol Psychiatry 2006 60 : 645 9.
28. Jibson MD, Tandon R. New atypical antipsychotic medications. J Psychiatr Res 1998 32 : 215 28.
29. Seamans JK, Durstewitz D, Christie BR, Stevens CF, Sejnowski TJ. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA 2001 98 : 301 6.
30. Chen L, Yang CR. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J Neurophysiol 2002 87 : 2324 36.